{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:38:00Z","timestamp":1791045480826,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0992"],"award-info":[{"award-number":["H16C0992"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["1711154218"],"award-info":[{"award-number":["1711154218"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.anai.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:47:36Z","timestamp":1684464456000},"page":"209-216.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice"],"prefix":"10.1016","volume":"131","author":[{"given":"Seong-Dae","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Mi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga-Young","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Seob","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Sim","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.anai.2020.04.025","article-title":"Predictive factors of response to inhaled corticosteroids in newly diagnosed asthma: a real-world observational study","volume":"125","author":"Rhyou","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.011_bib0002","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4168\/aair.2021.13.3.420","article-title":"Risk factors predicting severe asthma exacerbations in adult asthmatics: a real-world clinical evidence","volume":"13","author":"Ban","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.anai.2023.05.011_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104296","article-title":"Current and future targeted therapies for severe asthma: managing treatment with biologics based on phenotypes and biomarkers","volume":"146","author":"Santus","year":"2019","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.anai.2023.05.011_bib0004","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jaip.2021.02.059","article-title":"Cluster analysis of inflammatory biomarker expression in the International Severe Asthma Registry","volume":"9","author":"Denton","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.05.011_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4168\/aair.2021.13.3.375","article-title":"Biomarkers for severe asthma: lessons from longitudinal cohort studies","volume":"13","author":"Lee","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.anai.2023.05.011_bib0006","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/JAA.S274022","article-title":"Association between FeNO, total blood IgE, peripheral blood eosinophil and inflammatory cytokines in partly controlled asthma","volume":"13","author":"Badar","year":"2020","journal-title":"J Asthma Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2023.05.011_bib0008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.anai.2021.03.023","article-title":"Serum-free immunoglobulin E: a useful biomarker of atopy and type 2 asthma in adults with asthma","volume":"127","author":"Woo","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.05.011_bib0009","article-title":"Global strategy for asthma management and prevention GINA Main","year":"2022","journal-title":"REPORT"},{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2022.06.010","article-title":"What has been learned by cytokine targeting of asthma?","volume":"150","author":"Busse","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.011_bib0011","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaip.2021.10.054","article-title":"The development of the mucosal concept in chronic rhinosinusitis and its clinical implications","volume":"10","author":"Huang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2023.05.011_bib0012","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/all.14236","article-title":"Ceramide\/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma","volume":"75","author":"Kim","year":"2020","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.anai.2023.05.011_bib0013","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.jaip.2020.06.048","article-title":"Pragmatic clinical perspective on biologics for severe refractory type 2 asthma","volume":"8","author":"Chan","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2023.05.011_bib0014","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the Liberty ASTHMA QUEST study: a post-hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0015","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.anai.2023.05.011_bib0016","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fphar.2020.01147","article-title":"NSAID-exacerbated respiratory disease (NERD): from pathogenesis to improved care","volume":"11","author":"Woo","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.011_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI BioLogicals Guidelines\u2014recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.anai.2023.05.011_bib0018","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/all.13806","article-title":"Toward clinically applicable biomarkers for asthma: an EAACI position paper","volume":"74","author":"Diamant","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.05.011_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0813-0","article-title":"Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are We Asking the Right Question?","volume":"19","author":"Matucci","year":"2018","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.anai.2023.05.011_bib0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaip.2017.12.019","article-title":"Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma","volume":"6","author":"Ortega","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.05.011_bib0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3904\/kjim.2020.022","article-title":"Distinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications","volume":"35","author":"Choi","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.anai.2023.05.011_bib0022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/all.13997","article-title":"Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma","volume":"75","author":"Choi","year":"2020","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.05.011_bib0023","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.anai.2023.05.011_bib0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/cells10010019","article-title":"Discovery, function, and therapeutic targeting of Siglec-8","volume":"10","author":"Youngblood","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.anai.2023.05.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5753524","article-title":"Understanding the cellular sources of the fractional exhaled nitric oxide (FeNO) and its role as a biomarker of Type 2 inflammation in asthma","volume":"2022","author":"Escamilla-Gil","year":"2022","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.anai.2023.05.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01633-2019","article-title":"Clinical utility of fractional exhaled nitric oxide in severe asthma management","volume":"55","author":"Menzies-Gow","year":"2020","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/thorax.58.2.175","article-title":"Multiple roles of nitric oxide in the airways","volume":"58","author":"Ricciardolo","year":"2003","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0028","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2125.2011.03962.x","article-title":"Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE","volume":"72","author":"Lowe","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.011_bib0029","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell Fc\u03b5RI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.011_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and Fc\u03b5RI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623003393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623003393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:31:26Z","timestamp":1761053486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623003393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1081120623003393"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.05.011","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}